Replies to post #159883 on Biotech Values

[DewDiligence]

TMO-LIFE—Article in Boston Business Journal says TMO is overpaying:

http://www.bizjournals.com/boston/blog/bioflash/2013/04/analyst-thermo-fisher-paid-too-much.html

[DewDiligence]

Jonathan Rothberg resigns from TMO/LIFE:

http://www.sec.gov/Archives/edgar/data/1073431/000119312513271151/d559599dex991.htm

Dr. Jonathan Rothberg, Founder and CEO of Ion Torrent, has resigned his position with Life Technologies to pursue new opportunities. As a founder of four genetics companies, his departure from Life Technologies to seek his next entrepreneurial challenge is a natural next step, and we appreciate the deep bench of talent that Jonathan has built over the past three years to guide the long-term success of Ion Torrent.

[DewDiligence]

TMO (finally) closes LIFE acquisition; it took almost ten months:

http://finance.yahoo.com/news/thermo-fisher-scientific-completes-acquisition-230200635.html

Thermo Fisher Scientific (TMO), the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.